Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,182,831 papers from all fields of science
Search
Sign In
Create Free Account
Acne Vulgaris
Known as:
Acne
, Acne Vulgaris [Disease/Finding]
, Acne, vulgaris
A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
2 ML Clindamycin 150 MG/ML Injection
Benzoyl Peroxide
Benzoyl Peroxide 0.1 MG/MG Topical Gel
Benzoyl Peroxide 100 MG/ML Topical Cream
Expand
Broader (1)
Dermatitis
Narrower (2)
Dermatitis acneiform
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
T. Nakatsuji
,
M. Kao
,
+4 authors
Chun-Ming Huang
Journal of Investigative Dermatology
2009
Corpus ID: 205170715
The strong bactericidal properties of lauric acid (C12:0), a middle chain-free fatty acid commonly found in natural products…
Expand
Review
2006
Review
2006
Tetracyclines: nonantibiotic properties and their clinical implications.
A. Sapadin
,
R. Fleischmajer
Journal of American Academy of Dermatology
2006
Corpus ID: 31518009
Review
2006
Review
2006
Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006.
S. Hymes
,
E. Strom
,
C. Fife
Journal of American Academy of Dermatology
2006
Corpus ID: 36885121
Highly Cited
2005
Highly Cited
2005
What is the pathogenesis of acne?
C. C. Zouboulis
,
A. Eady
,
+4 authors
R. Rosenfield
Experimental Dermatology
2005
Corpus ID: 1233502
Abstract: For a long time, the mantra of acne pathogenesis debates has been that acne vulgaris lesions develop when (supposedly…
Expand
Highly Cited
2004
Highly Cited
2004
Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer.
E. Raymond
,
J. Alexandre
,
+7 authors
J. Armand
Journal of Clinical Oncology
2004
Corpus ID: 37252533
PURPOSE To establish the safety, tolerability, and pharmacokinetic parameters of CCI-779, a selective inhibitor of the mammalian…
Expand
Review
2001
Review
2001
Pathogenesis of acne
M. Toyoda
,
M. Morohashi
Medical Electron Microscopy
2001
Corpus ID: 23010221
Acne vulgaris is a skin disorder of the sebaceous follicles that commonly occurs in adolescence and in young adulthood. The major…
Expand
Highly Cited
1984
Highly Cited
1984
The assessment of acne vulgaris—the Leeds technique
B. M. Burke
,
W. Cunliffe
British Journal of Dermatology
1984
Corpus ID: 34059786
We describe two simple, reproducible scoring systems for assessing acne severity, and we emphasize the technical problems which…
Expand
Highly Cited
1979
Highly Cited
1979
Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid.
G. Peck
,
T. Olsen
,
+5 authors
J. Arnaud-Battandier
New England Journal of Medicine
1979
Corpus ID: 10339538
Fourteen patients with treatment-resistant cystic and conglobate acne were treated for four months with oral 13-cis-retinoic acid…
Expand
Highly Cited
1973
Highly Cited
1973
Toxicology of chlorinated dibenzo-p-dioxins.
B. Schwetz
,
Ii Norris
,
+5 authors
Acute Lethality
Environmental Health Perspectives
1973
Corpus ID: 7468457
Severe toxicological responses have been associated with certain chlorodibenzodioxins. One of these responses is chloracne, a…
Expand
Highly Cited
1970
Highly Cited
1970
Effects of local geology on ground motion near San Francisco Bay
R. Borcherdt
1970
Corpus ID: 130522296
abstract Measurements of ground motion generated by nuclear explosions in Nevada were made for 37 locations near San Francisco…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE